Articles tagged "Morbidity"

2020 American Transplant Congress
Geographic Distribution of End-Stage Renal Disease in the US: The First Description of an “ESRD Belt”
R. D. Reed¹, H. Qu¹, P. A. MacLennan¹, M. N. Mustian¹, D. Anderson¹, A. C. Kale¹, B. J. Orandi¹, B. A. Shelton¹, V. Kumar², M. J. Hanaway¹, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Medicine, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous research has demonstrated that population health is associated with organ supply and transplantation; this is particularly true in the southeastern United States, which…
2020 American Transplant Congress
Morbidity in Lung Transplant for Connective Tissue Disease
S. Minkove¹, E. Bush², P. Shah¹
¹Pulmonary and Critical Care, Johns Hopkins, Baltimore, MD, ²Thoracic Surgery, Johns Hopkins, Baltimore, MD
*Purpose: To evaluate the post-lung transplant comorbidities of patients with connective tissue disease (CTD) compared with an age-matched cohort of patients transplanted for idiopathic pulmonary…
2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
M. Park¹, Y. Gao¹, S. Schroeder², S. Siyahian¹, Z. Laszik¹, F. Vincenti¹
¹UCSF, San Francisco, CA, ²UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…
2019 American Transplant Congress
Positron Emission Tomography (PET-CT) Global Coronary Flow Reserve (CFR) Stratifies Cardiovascular Risk among Renal Transplant (RTx) Candidates
M. Minder, S. Mason, J. Ethington, R. McCubrey, D. Min, N. Sekaran, J. Orford, D. Morris, S. Anand, T. Srinivas
Intermountain Healthcare, Murray, UT
*Purpose: Chronic kidney disease (CKD) and diabetes (DM) are both associated with increased risk of coronary artery disease and Major Adverse Cardiovascular Events (MACE). The…
2019 American Transplant Congress
Clostridium difficile Infection Mimics Intestinal Acute Cellular Rejection in Pediatric Multivisceral Transplant – A Case Series
D. A. Cheung¹, T. Beduschi², A. Tekin², G. Selvaggi², R. M. Vianna², J. Garcia¹
¹Pediatric Gastroenterology, University of Miami, Miami, FL, ²Surgery, Division of Liver/GI Transplant, University of Miami, Miami, FL
*Purpose: Clostridium difficile infection (CDI) is the most common healthcare-associated infection in the United States. One out of 8 recipients who undergo transplantation with more…
2019 American Transplant Congress
Burden of Respiratory Virus Infections in Solid-Organ Transplant Recipients: A Nationwide Multi-Season Cohort Study
M. Mombelli¹, D. Neofytos², J. Aubert¹, C. Benden³, C. Berger³, K. Boggian⁴, A. Egli⁵, P. Gasche², H. Hirsch⁵, C. Hirzel⁶, N. Mueller³, C. Van Delden², O. Manuel¹
¹CHUV, Lausanne, Switzerland, ²HUG, Geneva, Switzerland, ³USZ, Zurich, Switzerland, ⁴KSSG, St. Gallen, Switzerland, ⁵USB, Basel, Switzerland, ⁶ISB, Bern, Switzerland
*Purpose: Respiratory virus infections (RVI) are common in solid-organ transplant recipients (SOTr) and are caused by a wide range of viruses. However, beside influenza, little…
2019 American Transplant Congress
Perioperative Blood Transfusion Significantly Increases Inpatient Morbidity and Mortality in Renal Transplant Recipients: 15-year Experience
K. Mahendraraj¹, G. Medrano del Rosal¹, M. Kruse¹, R. Shah¹, T. Katsichtis¹, T. Brennan², N. Nissen², T. Todo², K. Kosari², A. Klein², I. Kim²
¹Surgery, Lincoln Medical Center, New York, NY, ²Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: This study evaluates the immediate effects of perioperative blood transfusion (PBT) on inpatient morbidity and mortality among renal transplant (RT) recipients during their index…
2019 American Transplant Congress
Infective Complications after Renal Transplantation – A Single Centre Experience Comparing Alemtuzumab to Basiliximab Induction
R. Czajka, M. Welberry Smith, M. Gittus, E. Lindley, M. Vernon
Renal Medicine, St James' University Hospital, Leeds, United Kingdom
*Purpose: Our centre predominantly uses alemtuzumab as induction immunosuppression for renal transplantation. We examined infective complications after renal transplantation, comparing different induction, and maintenance, immunosuppression…
2019 American Transplant Congress
Association of Induction Immunosuppression Agents with Incidence of Cytomegalovirus Infection Following Kidney Transplantation
S. A. Medani, B. C. Astor, A. Djamali, M. A. Mohamed
Medicine- Nephrology, University of Wisconsin, Madison, WI
*Purpose:Cytomegalovirus (CMV) is the most common opportunistic infection following renal transplantation and can lead to significant morbidity. Inconsistency in adjusting for donor/recipient pre transplant CMV serostatus and in Alemtuzumab dosing probably contributed to…
2019 American Transplant Congress
Incisional Ventral Hernia Repair (IVHR) in Post Liver Transplant Recipients (OLT) through a Robotic-Assisted Intervention (RAI): Initial Single-Center Experience
A. Mejia, C. G. Fasola, A. Stegall
Liver Transplantation, Methodist Dallas Medical Center, Dallas, TX
*Purpose: To analyze the outcome of IVH repairs in liver transplant recipients using a minimally invasive technique.*Methods: From 2016 to 2018, we analyzed the IVHR…